Sub-typing of rheumatic diseases based on a systems diagnosis questionnaire

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  van Wietmarschen, Herman A ^a,b   Reijmers, Theo H ^a,c   van der Kooij, Anita J ^c   Schroën, Jan ^b,d   Wei, Heng ^b,e   Hankemeier, Thomas ^a,b,c   Meulman, Jacqueline J ^c   van der Greef, Jan ^a,b,e  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Sino Dutch Centre for Preventive and Personalized Medicine   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d Oxrider Education and Research   (Netherlands)

^e TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DICLOFENAC; ETORICOXIB; HYDROXYCHLOROQUINE; IBUPROFEN; METHOTREXATE; NAPROXEN; PARACETAMOL; PREDNISONE; TRAMADOL;

ANXIETY; ARTICLE; AVERSIVE BEHAVIOR; CHINESE MEDICINE; CLINICAL ARTICLE; COMMON COLD SYMPTOM; DISTRESS SYNDROME; DYSPNEA; FIBROMYALGIA; HEAT SENSATION; HUMAN; NERVOUSNESS; OSTEOARTHRITIS; PRINCIPAL COMPONENT ANALYSIS; QUESTIONNAIRE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THIRST; XEROSTOMIA; BIOLOGICAL MODEL; CLASSIFICATION; COLD; HEAT;

COLD TEMPERATURE; HOT TEMPERATURE; HUMANS; MODELS, BIOLOGICAL; QUESTIONNAIRES; RHEUMATIC DISEASES;

EID: 80052843185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024846     Document Type: Article

References (50)

1. Anderson JJ, Wells G, Verhoeven AC, Felson DT, (2000) Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 43 (1): 22-29.
2. Smolen JS, Aletaha D, (2005) Challenges of predicting treatment response in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 1 (2): 62-63.
3. Rindfleisch JA, Muller D, (2005) Diagnosis and management of rheumatoid arthritis. Am Fam Physician 72 (6): 1037-47.
4. Van der Greef J, McBurney RN, (2005) Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov 4: 961-7.
5. Glocker MO, Guthke R, Kekow J, Thiesen H, (2006) Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev 26 (1): 63-87.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (3): 315-24.
7. Lindström B, Eriksson M, (2005) Salutogenesis. J Epidemiol Community Health 59 (6): 440-2.
8. van der Greef J, Martin S, Juhasz P, Adourian A, Plasterer T, et al. (2007) The art and practice of systems biology in medicine: mapping patterns of relationships. J Proteome Res 6 (4): 1540-59.
9. Verhoeckx KCM, Bijlsma S, Jespersen S, Ramaker R, Verheij E, et al. (2004) Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis. Int Immunopharmacol 4 (12): 1499-514.
10. van der Greef J, Stroobant P, van der Heijden R, (2004) The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 8 (5): 559-65.
11. Gaston JSH, (2008) Cytokines in arthritis-the 'big numbers' move centre stage. Rheumatology (Oxford) 47: 8-12.
12. Lundy SK, Sarkar S, Tesmer LA, Fox DA, (2007) Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 9: 202.
13. van der Helm-van Mil AHM, Huizinga TWJ, de Vries RRP, Toes REM, (2007) Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. Arthritis Rheum 56 (6): 1728-35.
14. Van der Helm-van Mil AHM, Verpoort KN, Breedveld FC, Toes REM, Huizinga TWJ, (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7 (5): R949-58.
15. van der Pouw Kraan TCTM, Wijbrandts CA, van Baarsen LGM, Voskuyl AE, Rustenburg F, et al. (2007) Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 66 (8): 1008-14.
16. van Middendorp H, Geenen R, Sorbi MJ, van Doornen LJP, Bijlsma JWJ, (2009) Health and physiological effects of an emotional disclosure intervention adapted for application at home: a randomized clinical trial in rheumatoid arthritis. Psychother Psychosom 78 (3): 145-151.
17. van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P, (2010) Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 49 (7): 1294-302.
18. Wells GA, (2009) Patient-driven outcomes in rheumatoid arthritis. J Rheumatol Suppl 82 pp. 33-38.
19. Treharne GJ, Lyons AC, Booth DA, Kitas GD, (2007) Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. Br J Health Psychol 12 (Pt 3): 323-345.
20. van der Greef J, van Wietmarschen H, Schroën J, Wang M, Hankemeier T, et al. (2010) Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. Planta Med 76 (17): 2036-2047.
21. Maciocia G, (2005) The Foundations of Chinese Medicine: A Comprehensive Text for Acupuncturists and Herbalists. Second Edition Churchill Livingstone.
22. Vandeginste BGM, Massart DL, Buydens LMC, De Jong S, Lewi PJ, et al. (1998) Handbook of Chemometrics and Qualimetrics Part B. Elsevier, Amsterdam.
23. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, et al. (2007) Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol 1 (1): 51-60.
24. Ni M, (1995) The Yellow Emperor's Classic of Medicine: A New Translation of the Neijing Suwen with Commentary. 1st ed Shambhala.
25. Jiang W, (2005) Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 26: 558-63.
26. van Wietmarschen HA, Yuan K, Lu C, Gao P, Wang JS, et al. (2009) Systems biology guided by Chinese Medicine reveals new markers for sub-typing rheumatoid arthritis patients. Journal of Clinical Rheumatology 15 (7): 330-337.
27. Lu C, Zha Q, Chang A, He Y, Lu A, (2009) Pattern Differentiation in Traditional Chinese Medicine Can Help Define Specific Indications for Biomedical Therapy in the Treatment of Rheumatoid Arthritis. J Altern Complement Med 15 (9): 1021-1025.
28. Vangermeersch L, (1994) Bi-syndromes Brussels Satas.
29. Likert R, (1932) A Technique for the Measurement of Attitudes. Archives of Psychology 140: 1-55.
30. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, et al. (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 36 (6): 729-40.
31. Markus MT, (1994) Bootstrap confidence regions in nonlinear multivariate analysis Leiden, The Netherlands DSWO Press.
32. Borgatti SP, Everett MG, (1997) Network analysis of 2-mode data. Social Networks 19 (3): 243-269.
33. Borgatti S, Mehra A, Brass D, Labianca G, (2009) Network Analysis in the Social Sciences. Science 323 (5916): 892-895.
34. Strogatz SH, (2001) Exploring complex networks. Nature 410 (6825): 268-76.
35. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2 (10): 2366-82.
36. Kamada T, Kawai S, (1989) An algorithm for drawing general undirected graphs. Information Processing Letters 31 (1): 7-15.
37. SAS Institute Inc (2009) SAS/ STAT Software Cary, N.C. Sas Institute Inc.
38. SAS Institute Inc (2009) SAS/ STAT 9.2 User's guide Cary, N.C. Sas Institute Inc.
39. Young F, Takane Y, de Leeuw J, (1978) The principal components of mixed measurement level multivariate data: An alternating least squares method with optimal scaling. Psychometrika 43: 279-281.
40. SPSS Inc (2009) PASW Statistics 17.0 Chicago, Il. SPSS Inc.
41. Gifi A, (1990) Nonlinear multivariate analysis Chichester, England Wiley.
42. Meulman JM, Heiser WJ, SPSS Inc, (2009) SPSS Categories 17.0 Chicago, Il. SPSS Inc.
43. Horn J, (1965) A rationale and test for the number of factors in factor-analysis. Psychometrika 30 (2): 179-185.
44. Zwick WR, Velicer WF, (1986) Comparison of five rules for determining the number of components to retain. Psychological Bulletin 99 (3): 432-442.
45. Buja A, Eyuboglu N, (1992) Remarks on parallel analysis. Multivariate behavioral research 27 (4): 509-540.
46. Meulman in: Kaplan D. The Sage handbook of quantitative methodology for the social sciences. SAGE; 2004, Chapter 3.
47. Hendriks MMWB, Smit S, Akkermans WLMW, Reijmers TH, Eilers PHC, et al. (2007) How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Proteomics 7 (20): 3672-3680.
48. Ganter B, Zidek N, Hewitt PR, Müller D, Vladimirova A, (2008) Pathway analysis tools and toxicogenomics reference databases for risk assessment. Pharmacogenomics 9 (1): 35-54.
49. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437 (7061): 1032-7.
50. Zhou X, Liu B, Wu Z, Feng Y, (2007) Integrative mining of traditional Chinese medicine literature and MEDLINE for functional gene networks. Artif Intell Med 41 (2): 87-104.